Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Xarelto Atrial Fibrillation Data Suggest Lines Of Advisory Committee Inquiry

Aug 15 2011

• By Sue Sutter

Related Content

J&J Xarelto Liver Profile Key To Committee Vote; New Data Offer Assurance

Mar 23 2009

<i>Pradaxa</i> Review Shows FDA Doubts About The Power Of REMS To Change Prescribing Practices

Apr 01 2011

FDA Approval Of <i>Xarelto</i> Bodes Well For Drug’s Future Expansion

Jul 11 2011

Bayer/J&J Will Resubmit Xarelto For Acute Indication In Second Half Along With New Application For Chronic Use

Feb 26 2010

ROCKET AF Yields Positive Results For Xarelto, But A Few Chinks In The Armor

Nov 22 2010

FDA Pradaxa Approval Balances Efficacy And Bleeding Risk

Oct 25 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window